Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7DQ, UK.
Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Nuffield Department of Medicine Research Building, Oxford OX3 7FZ, UK.
Sci Adv. 2023 Sep 29;9(39):eadg8229. doi: 10.1126/sciadv.adg8229.
In this study, we present the structures of human urea transporters UT-A and UT-B to characterize them at molecular level and to detail the mechanism of UT-B inhibition by its selective inhibitor, UTB-14. High-resolution structures of both transporters establish the structural basis for the inhibitor's selectivity to UT-B, and the identification of multiple binding sites for the inhibitor will aid with the development of drug lead molecules targeting both transporters. Our study also discovers phospholipids associating with the urea transporters by combining structural observations, native MS, and lipidomics analysis. These insights improve our understanding of urea transporter function at a molecular level and provide a blueprint for a structure-guided design of therapeutics targeting these transporters.
在这项研究中,我们呈现了人尿素转运体 UT-A 和 UT-B 的结构,以在分子水平上对它们进行表征,并详细阐述其选择性抑制剂 UTB-14 的抑制机制。两种转运体的高分辨率结构为抑制剂对 UT-B 的选择性提供了结构基础,并且确定了抑制剂的多个结合位点将有助于开发针对这两种转运体的药物先导分子。我们的研究还通过结合结构观察、天然 MS 和脂质组学分析发现了与尿素转运体相关的磷脂。这些见解提高了我们对尿素转运体在分子水平上的功能的理解,并为针对这些转运体的基于结构的治疗药物设计提供了蓝图。